1 minute read
Nationally Prioritised Innovations
2021-22 programme details Nationally Prioritised Innovations
Context for our work:
The NHS is innovative and resourceful. It is regularly inventing and iterating, however numerous reports evidence that the NHS is poor at systematically adopting proven innovations – innovations which have an evidence base, are considered impactful and are available to use. Innovation adoption often takes place in pockets by those who champion its use. This isn’t new and reflects a growing recognition that the process of adoption is not straight forward. The AHSN has a goal of overturning this.
Aims:
The NPI programme aims to enable Wessex to successfully adopt more innovations faster in order to improve the lives of our citizens and improve the quality and efficiencies of the NHS organisation we support. We focus on proven innovations prioritised via national programmes such as the Accelerated Access Collaborative (AAC) and the NHS Innovation Accelerator (NIA) programme.
Key objectives:
Work collaboratively with our members to support the spread and adoption, implementation and sustainability of prioritised innovations across Wessex. Generate pull for proven innovation in Wessex by supporting our region to develop the cultures and methods to accelerate the adoption of proven innovation.
Key deliverables
Lead and deliver the national Accelerated Access Collaborative FeNO programme on behalf of the AHSN Network.
Deliver the four 2021-22 ACC Rapid Uptake Programmes locally, comprising Tamoxifen, asthma biologics, lipids and FeNO testing.
Support the transition to the new NHS England/Improvement MedTech Funding Mandate (MTFM).
Enable the successful adoption of the wave 2 MTFM products across Wessex, or understand barriers to adoption.
Deliver two innovation adoption masterclasses in Wessex.
Explore and support the use of the 2021-22 NIA innovations in Wessex.
